![]()
|
|
||||||||
J Biol Chem, Vol. 274, Issue 27, 18916-18924, July 2, 1999
,
,
,
,
, and
From the Human blood contains a form of minimally modified
low density lipoprotein (LDL), termed LDL
Department of Molecular Pharmacology and
Toxicology,
Washington
University School of Medicine, St. Louis, Missouri 63110, and

Karl-Franzens Universitat Graz,
Graz A8010, Austria
, whose
origin remains unknown. Exploring the mechanism of formation, we found
that LDL
can be produced in plasma in the absence of
oxygen following LDL incubation with oxidized hemoglobin species. A
high degree of apolipoprotein B100 modification results from covalent
association of hemoglobin with LDL involving dityrosine formation but
not due to the malonaldehyde epitope formation. This was evidenced by
the cross-reactivity of oxidized LDL with antibodies against hemoglobin
that was accompanied by a 60-fold increase in dityrosine levels. In
this study we found significantly higher LDL
levels in
the blood of hemodialysis patients, perhaps contributing to their
greatly increased risk of atherosclerosis. The mechanism of
LDL
formation was studied during ex vivo
blood circulation using a model system resembling clinical hemodialysis
in terms of the induction of inflammatory responses. This circulation
increased free hemoglobin and LDL
levels compared with
non-circulated blood without appreciable lipid peroxidation. Pronounced
increases in LDL
were found also during circulation of
plasma supplemented with nanomolar hemoglobin levels. The increase in
dityrosine content and presence of heme in LDL after blood circulation
suggest that LDL is modified, in part, by hemoglobin-LDL conjugates
containing heme. Thus, hemoglobin-mediated reactions leading to LDL
oxidation in plasma can account for high LDL
levels in
hemodialysis patients.
Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.
This article has been cited by other articles:
![]() |
M. Kanayama, S. Yamaguchi, T. Shibata, N. Shibata, M. Kobayashi, R. Nagai, H. Arai, K. Takahashi, and K. Uchida Identification of a Serum Component That Regulates Cyclooxygenase-2 Gene Expression in Cooperation with 4-Hydroxy-2-nonenal J. Biol. Chem., August 17, 2007; 282(33): 24166 - 24174. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Watanabe, K. J. Chou, J. C. Liao, Y. Miao, H.-H. Meng, H. Ge, V. Grijalva, S. Hama, K. Kozak, G. Buga, et al. Differential Association of Hemoglobin with Proinflammatory High Density Lipoproteins in Atherogenic/Hyperlipidemic Mice: A NOVEL BIOMARKER OF ATHEROSCLEROSIS J. Biol. Chem., August 10, 2007; 282(32): 23698 - 23707. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Meier, F. Spertini, E. Blanc, and M. Burnier Oxidized Low-Density Lipoproteins Activate CD4+ T Cell Apoptosis in Patients with End-Stage Renal Disease through Fas Engagement J. Am. Soc. Nephrol., January 1, 2007; 18(1): 331 - 342. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. DeMaio, M. Rouhanizadeh, S. Reddy, A. Sevanian, J. Hwang, and T. K. Hsiai Oxidized phospholipids mediate occludin expression and phosphorylation in vascular endothelial cells Am J Physiol Heart Circ Physiol, February 1, 2006; 290(2): H674 - H683. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Arai, B. S. Berlett, P. B. Chock, and E. R. Stadtman Effect of bicarbonate on iron-mediated oxidation of low-density lipoprotein PNAS, July 26, 2005; 102(30): 10472 - 10477. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Asatryan, R. T. Hamilton, J. M. Isas, J. Hwang, R. Kayed, and A. Sevanian LDL phospholipid hydrolysis produces modified electronegative particles with an unfolded apoB-100 protein J. Lipid Res., January 1, 2005; 46(1): 115 - 122. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Wanner, U. Bahner, R. Mattern, D. Lang, and J. Passlick-Deetjen Effect of dialysis flux and membrane material on dyslipidaemia and inflammation in haemodialysis patients Nephrol. Dial. Transplant., October 1, 2004; 19(10): 2570 - 2575. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Ziouzenkova, L. Asatryan, D. Sahady, G. Orasanu, S. Perrey, B. Cutak, T. Hassell, T. E. Akiyama, J. P. Berger, A. Sevanian, et al. Dual Roles for Lipolysis and Oxidation in Peroxisome Proliferation-Activator Receptor Responses to Electronegative Low Density Lipoprotein J. Biol. Chem., October 10, 2003; 278(41): 39874 - 39881. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Asatryan, O. Ziouzenkova, R. Duncan, and A. Sevanian Heme and lipid peroxides in hemoglobin-modified low-density lipoprotein mediate cell survival and adaptation to oxidative stress Blood, September 1, 2003; 102(5): 1732 - 1739. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Balla, G. M. Vercellotti, K. Nath, A. Yachie, E. Nagy, J. W. Eaton, and G. Balla Haem, haem oxygenase and ferritin in vascular endothelial cell injury Nephrol. Dial. Transplant., July 1, 2003; 18(90005): v8 - 12. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Jeney, J. Balla, A. Yachie, Z. Varga, G. M. Vercellotti, J. W. Eaton, and G. Balla Pro-oxidant and cytotoxic effects of circulating heme Blood, July 18, 2002; 100(3): 879 - 887. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. URSINI and A. SEVANIAN Wine Polyphenols and Optimal Nutrition Ann. N.Y. Acad. Sci., May 1, 2002; 957(1): 200 - 209. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. D'Agnillo and A. I. Alayash Redox cycling of diaspirin cross-linked hemoglobin induces G2/M arrest and apoptosis in cultured endothelial cells Blood, December 1, 2001; 98(12): 3315 - 3323. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-i. Toshima, A. Hasegawa, M. Kurabayashi, H. Itabe, T. Takano, J. Sugano, K. Shimamura, J. Kimura, I. Michishita, T. Suzuki, et al. Circulating Oxidized Low Density Lipoprotein Levels : A Biochemical Risk Marker for Coronary Heart Disease Arterioscler. Thromb. Vasc. Biol., October 1, 2000; 20(10): 2243 - 2247. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |